General Information
Version
CLP_F
Revision date
2022-10-07
Product name
Isopropyl chloroformate
CAS No.
108-23-6
REACH No
01-2119943484-33-0002;
Emergency telephone
+36 80 201 199, +36 1 476 6464
Icons in SDS
Company Information
company name
Framochem French-Hungarian Fine Chemicals Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info@framochem.hu
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H225, H302, H314, H330
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
CLP CLASSIFICATION
Flammable liquids, Hazard Category 2 – H225 Acute toxicity (oral), Hazard Category 4 – H302 Skin corrosion/irritation, Hazard Category 1B – H314 Acute toxicity (inhalation), Hazard Category 2 – H330
Hazard statements
H225 – Highly flammable liquid and vapour. H302 – Harmful if swallowed. H314 – Causes severe skin burns and eye damage. H330 – Fatal if inhaled. H225 – Highly flammable liquid and vapour. H302 – Harmful if swallowed. H314 – Causes severe skin burns and eye damage. H330 – Fatal if inhaled.
2.2 Label elements
IUPAC name: Isopropyl chloroformate CAS number: 108-23-6 EC number: 203-563-2 DANGER Framochem French-Hungarian Fine Chemicals Ltd. Isopropyl chloroformate 1 / 10.
Precautionary statements
P202 – Do not handle until all safety precautions have been read and understood. P220 – Keep away from clothing and other combustible materials. P308 + P313 – IF exposed or concerned: Get medical advice/attention. P280 – Wear protective gloves/protective clothing/eye protection/face protection. P305 + P351 + P338 – IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 – If eye irritation persists: Get medical advice/attention.
2.3 Other hazards
The substance has no other known specific hazards for human or environment. Information concerning specific hazards for human and environment: see Section 11. The substance does not meet the PBT or vPvB criteria according to Annex XIII of Regulation